Skip to main content

Part of the book series: BestMasters ((BEST))

  • 876 Accesses

Abstract

Understanding the actions taken by pharmaceutical firms in order to thwart competition requires the information on how the pharmaceutical sector is constructed. The pharmaceutical market, referred to in this paper, contains all firms that produce or develop pharmaceuticals or compounds that are used to produce drugs and all other participants that interact with those firms for the purpose of selling or purchasing a drug, not regarding other healthcare products. Furthermore, understanding of which market participants exist and how important it is for an economy to keep this sector growing by supporting its production and development, is required to understand anticompetitive actions performed by pharmaceutical innovators.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ann-Kathrin Lehnhausen .

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Fachmedien Wiesbaden GmbH

About this chapter

Cite this chapter

Lehnhausen, AK. (2017). The Pharmaceutical Industry. In: Studies on Competition and Antitrust Issues in the Pharmaceutical Industry. BestMasters. Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-16551-2_2

Download citation

Publish with us

Policies and ethics